Development of potency assays for a plasmid containing vascular endothelial growth factor 2
We have developed analytical methods to measure the biological functions of pVGI.1(VEGF2), a naked plasmid DNA product containing vascular endothelial growth factor 2 used in clinical trials for coronary artery diseases (CAD) and peripheral artery diseases (PAD). After being injected into muscles, v...
Guardado en:
Autores principales: | Huang,Li-chun, Chin,Emily, Chiang,Yawen L |
---|---|
Lenguaje: | English |
Publicado: |
Pontificia Universidad Católica de Valparaíso
2010
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34582010000100001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
por: Amer H. Tarawneh, et al.
Publicado: (2022) - Plasmid a journal of molecular genetics with emphasis on plasmid biology.
-
Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
por: Gina Durán, et al.
Publicado: (2021) -
Study of Indonesia’s Solar Energy Implementation Using Identification of Potency, Policies, and Cost-Benefit Analysis
por: Mochammad Donny Anggoro, et al.
Publicado: (2021) -
Botanical potency of Chromolaena odorata linn (Hagonoy) as mosquitocidal
por: John Michael Sasan, et al.
Publicado: (2021)